Huntington National Bank’s AbbVie ABBV Stock Holding History

Huntington National Bank’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$162M	Buy	745,449 +28,685	+4%	+$6.36M	0.89%	22
2025 Q4	$164M	Buy	716,764 +17,446	+2%	+$3.97M	0.98%	23
2025 Q3	$162M	Buy	699,318 +24,310	+4%	+$4.95M	0.99%	24
2025 Q2	$125M	Buy	675,008 +53,577	+9%	+$9.96M	0.82%	29
2025 Q1	$130M	Buy	621,431 +90,269	+17%	+$17.5M	0.94%	27
2024 Q4	$94.4M	Buy	531,162 +6,943	+1%	+$1.28M	0.67%	39
2024 Q3	$104M	Sell	524,219 -27	-0%	-$5.04K	0.75%	31
2024 Q2	$89.9M	Buy	524,246 +7,883	+2%	+$1.31M	0.7%	35
2024 Q1	$94M	Sell	516,363 -11,344	-2%	-$1.96M	0.76%	30
2023 Q4	$81.8M	Sell	527,707 -23,233	-4%	-$3.39M	0.74%	30
2023 Q3	$82.1M	Sell	550,940 -30,478	-5%	-$4.47M	0.82%	28
2023 Q2	$78.3M	Sell	581,418 -42,001	-7%	-$6.16M	0.73%	34
2023 Q1	$99.4M	Sell	623,419 -152,011	-20%	-$23.2M	0.99%	25
2022 Q4	$125M	Buy	775,430 +31,974	+4%	+$4.9M	1.31%	17
2022 Q3	$99.8M	Buy	743,456 +60,065	+9%	+$8.62M	1.14%	20
2022 Q2	$105M	Buy	683,391 +172,196	+34%	+$26.3M	1.13%	18
2022 Q1	$82.9M	Buy	511,195 +9,795	+2%	+$1.42M	0.77%	32
2021 Q4	$67.9M	Sell	501,400 -3,839	-0.8%	-$453K	0.62%	43
2021 Q3	$54.5M	Sell	505,239 -3,545	-0.7%	-$405K	0.54%	58
2021 Q2	$57.3M	Buy	508,784 +85,537	+20%	+$9.63M	0.57%	54
2021 Q1	$45.8M	Sell	423,247 -10,328	-2%	-$1.1M	0.55%	61
2020 Q4	$46.5M	Sell	433,575 -2,462	-0.6%	-$237K	0.61%	52
2020 Q3	$38.2M	Sell	436,037 -2,488	-0.6%	-$234K	0.56%	55
2020 Q2	$43.1M	Sell	438,525 -277	-0.1%	-$24.4K	0.68%	46
2020 Q1	$33.4M	Sell	438,802 -31,197	-7%	-$2.66M	0.63%	50
2019 Q4	$41.6M	Sell	469,999 -16,863	-3%	-$1.4M	0.63%	51
2019 Q3	$36.9M	Buy	486,862 +74,528	+18%	+$5.11M	0.59%	55
2019 Q2	$30M	Sell	412,334 -25,973	-6%	-$2.04M	0.48%	62
2019 Q1	$35.3M	Sell	438,307 -68,526	-14%	-$5.61M	0.58%	51
2018 Q4	$46.7M	Sell	506,833 -17,474	-3%	-$1.54M	0.83%	29
2018 Q3	$49.6M	Buy	524,307 +4,935	+1%	+$468K	0.78%	34
2018 Q2	$48.1M	Buy	519,372 +8,006	+2%	+$782K	0.8%	31
2018 Q1	$48.4M	Buy	511,366 +2,457	+0.5%	+$270K	0.81%	32
2017 Q4	$49.2M	Buy	508,909 +6,723	+1%	+$634K	0.79%	33
2017 Q3	$44.6M	Buy	502,186 +105,236	+27%	+$8.01M	0.75%	34
2017 Q2	$28.8M	Sell	396,950 -19,348	-5%	-$1.3M	0.51%	61
2017 Q1	$27.1M	Sell	416,298 -25,491	-6%	-$1.6M	0.48%	64
2016 Q4	$27.7M	Sell	441,789 -13,248	-3%	-$809K	0.5%	60
2016 Q3	$28.7M	Buy	455,037 +65,027	+17%	+$4.21M	0.53%	57
2016 Q2	$24.1M	Sell	390,010 -124,817	-24%	-$7.61M	0.6%	51
2016 Q1	$30.1M	Buy	514,827 +78,270	+18%	+$4.36M	0.74%	33
2015 Q4	$25.9M	Sell	436,557 -95,056	-18%	-$5.47M	0.65%	41
2015 Q3	$28.9M	Buy	531,613 +4,337	+0.8%	+$282K	0.76%	29
2015 Q2	$35.4M	Buy	527,276 +12,449	+2%	+$813K	0.86%	24
2015 Q1	$30.1M	Buy	514,827 +43,233	+9%	+$2.61M	0.74%	33
2014 Q4	$30.9M	Sell	471,594 -5,089	-1%	-$321K	0.74%	33
2014 Q3	$27.5M	Sell	476,683 -84,638	-15%	-$4.7M	0.56%	45
2014 Q2	$31.7M	Buy	561,321 +21,893	+4%	+$1.15M	0.62%	32
2014 Q1	$27.7M	Buy	539,428 +35,664	+7%	+$1.8M	0.53%	38
2013 Q4	$26.6M	Buy	503,764 +3	+0%	+$147	0.7%	31
2013 Q3	$22.5M	Buy	503,761 +458	+0.1%	+$20.3K	0.67%	36
2013 Q2	$20.8M	Buy	+503,303	New	+$22M	0.65%	34

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Huntington National Bank's ABBV Position: Q1 2026 in Review

Huntington National Bank increased its AbbVie (ABBV) stake by 4% in Q1 2026, buying an estimated $6.36M and bringing the position to 745,449 shares worth $162M. The position accounts for 0.89% of the portfolio, ranked #22.

Huntington National Bank first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $164M in Q4 2025. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Huntington National Bank held 745,449 shares of AbbVie worth $162M as of Q1 2026.
Huntington National Bank bought 28,685 AbbVie shares in Q1 2026, an estimated $6.36M.
AbbVie made up 0.89% of Huntington National Bank's portfolio in Q1 2026, its #22 holding.
Huntington National Bank first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
Huntington National Bank's AbbVie position peaked at $164M in Q4 2025.
4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.